How the US Pandemic Preparedness Failed: Harvard’s Dr. Ashish Jha on the Best Way Forward Through Covid-19
This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Ashish Jha, Director of the Harvard Global Health Institute, who is advising state, federal and international governments on Covid-19. He laments the delayed and inadequate response by the federal government to the threat of Covid-19, how failure to deploy a cohesive testing strategy has cost lives, and how an aggressive national approach is needed to safely navigate the way through this pandemic. He predicts the coronavirus will change training of future health professionals, as well as the way the American health care system is run.
Dr. Ashish Jha
[ M us ic ]
Moderator: Welcome to Conversations on Health Care with Mark Masselli
and Margaret Flinter, a show where we speak to the top
thought leaders in health innovation, health policy, care
delivery, and the great minds who are shaping the hea lthca re
of t he future.
This week, Mark and Margaret speak with Dr. Ash ish Jha ,
Director of the Harv ard Global Health Institute, an internist
and Professor of Global Health at the Harvard TH Chan School
of Public Health. He's a leading advisor to state, federal and
int ernational governments addressing the COVID - 19
pandemic. He says poor rollout of testing across the US has led
to worse outcomes and warns that without adequate testing
and contact tracing moving forward, we could see a real
problem unfold when the economy reopens. Lori Robertson
also checks in Managing Editor of factcheck.org looks at
misstatements spoken about health policy in the public
domain separating the fak e from the facts and we end with a
bright idea th at is improving health and well being and
ever yday lives. If you hav e comments, please email us at
[email protected] or find us on Facebook, Twitter, or
wherever you listen to podcasts and you can ask Alexa to play
the program. Now stay tuned for our interview w ith Dr. Ashish
Jha h ere at Conversations on Health Care.
Mark Masselli: We're speaking today with Dr. Ashish Jha, Director of the
Harvard Global Health Institute or practicing general internist.
Dr. Jha is the K.T. Li Professor of Global Health a t Harvar d's TH
Chan School of Public Health. He's a member of the Institute of
Medicine at the National Academies of Science, Engineering
and medicine. He'll begin his work as dean at Brown University
School of Public Health in the fall.
Margaret Flinter: Dr. J ha’ s research has focused on improving the quality and
the cost of healthcare systems with a particular emphasis on
the impact of public policy. He has led groundbreaking work
on public health responses to epidemics like Ebola, and now
leading a national anal ysis of the COVID - 19 pandemic and
advising our state and federal policymakers on the crisis. Dr .
Jha w e welcome you back to Conversations on Healthcare .
Dr. Ashish Jha: Thanks for having me back.
Mark Masselli: And congratulations on going to B rown. I gues s you'll be going
there virtually, or maybe you'll be there in person as well but.
Dr. Ashish Jha: I'm hoping that I'll be there in person since we are starting i n
Dr. Ashish Jha
the fall, we'll see how it all goes.
Mark Masselli: You've been such a great spokesperson an d expert on the
COVID - 19 pandemic. You've been testifying in front of
congressional hearings on what needs to be done to get ahead
of this global threat and you have a pretty unvarnished
assessment of the actions taken by the United States
government, sinc e the Coronavirus began to take hold. And
you say the actions are really inadequate, particularly around
testing and the United States seems to have fared far worse
th an countries around the globe and I'm wondering if you
could talk to our listeners a litt le bit about where we stand in
that. What's your prescription for how we can improve the
testing? Testing is foremost on many people's mind.
Dr. Ashish Jha: And so this really has r eally quite an unfortunate response by
our federal government. I think it's sort of borders on, a
disaster just really badly handled . And if you ask the question,
w ell, why do I use strong words like that? What does that
mean? You know, one of the things that we've learned from
almost every disease outbreak, but boy, this virus m ore than
most, is that if you fall behind, and if you don't take it
seriously, it is a punishing virus. A lot of people have gotten
sick. As of right now, more than 90,000 Americans have died.
That's a bit of a disaster. And I think much of it was
preventa ble. It wasn't going to be easy. People say, w ell, you
know, wouldn't have been hard. And the answer is yes, it
would have be en hard to prevent those 90,000 deaths. So,
what should have happened is we should have developed a
testing scheme early by kind of mid January WHO had a test
kit we could have used that , we could have developed our
own and when we when we try to develop our own and it
didn't work, we should have moved quickly to harnessing the
private sector. There are lots and lots of opportunities, we
basically wasted about six to eight weeks , n ot developing a
test and two months is a long time to lose in a pandemic. So
that was really the original sin in many ways, and driven partly
by bureaucratic incompetence. But a lot by leadership at in the
Wh ite House that didn't want to see t esting that really saw
testing a s somehow an enemy because it would reveal the
number of cases we had. And one of the things I've tried to
point out, testing doesn't give you cases, the virus gives you
cases, testing help s you identify them and do something about
it. And this has been like, instead of dealing with the fire, we
put it under the bed and hope that it would go away and now
the entire bed is on fire. And we're wondering how did this
happen? We know how it happe ned. And the failures are not
just in testing. They're really much broader than that. And I
Dr. Ashish Jha
don't want to be only negative they've been a fabulous work
by Governor's Democrats and Republicans, other political
leaders. But really the hallmark of this outbre ak has been the
failure of federal leadership.
Margaret Flinter: Well, Dr. Jha , you're not alone in that somewhat grim
assessment of where we haven't done well, you recently
testified before congressional hearing on public policies
needed to now help us sa fely reopen the economy. And you're
joined by experts who served administration's from both sides
of the aisle, Scott Gottlieb, the recent FDA Commissioner
under President Trump and Mark McClellan, who of course
served in the B ush administration, no disagr eement about the
need for more testing as a fundamental precursor to
reopening the country and the economy. And you've now
released a series of recommendations to follow for to meet
the criteria for safely reopening , share those with us.
Dr. Ashish Jha: In terms of reopening, I actually think the there have been of
various different guidelines on how best to do it. But in many
ways, I'm actually going to go back to the White House
g uidelines, which I still think i n some ways, the most
important, the Whiteho use put out the opening up America
again guidelines. And I had some disagreements with parts of
it, but largely they were right. They were scientifically
grounded. And if you want to think about how to open up
safely, you want 14 days of declining cases, y ou want a
relatively low number of ongoing new cases happening. And
then you want a robust testing infrastructure of testing and
tracing. Our assessment is that you need about 900,000 tests a
day in this country. Others have suggested we need like 5
millio n tests a day. There are plenty of disagreements among
experts , bu t the one area we all agree is everybody agrees we
need a lot more than that. And so then people say, w ell, does
that mean we can't open up and my answer is you can always
open up . The quest ion is can you stay open and in order to
stay open, you have to have a strategy that includes ongoing
social dis tancing. Probably universal mask wearing , testing
tracing and isolation. The less testing you have, the more of
the other things you have to do. So testing is a way to reduce
your caseload. And if you don't have much testing, then you
have to put in much more in the way of social distancing and
stringent policies. And what I have been encouraging states to
do and municipalities to do is really bui ld up their testing
capacity, so that we can get more of our economy back more
of our lives back. We're not goi ng back to normal anytime
soon.
Dr. Ashish Jha
Margaret Flinter: Yeah.
Mark Masselli: Yeah. Just wondering conceptually about, you know, it seems
like the gover nment had a rudder on the boat and then took
the rudder out. But how are you viewing the country as a
whole though? It is it should it be driven b ut really, it's such a
large country? How do you approach it conceptually? Do you
think about states that are in various stages of ability to stand
things up? How should they proceed?
Dr. Ashish Jha: Yeah, so we are a vast country and this is why we've always
had a very interesting structure and approach to health, which
has always had a very prominent role for st ates. And I always
say that, Montana has got a very different set of challenges
with COVID, than Manhattan does. And the idea that the same
policy that would work in New York would be the same policy
that would work in Montana, almost surely not true. Ther e are
a lot of important differences. So there has been a long
standing agreement in public health between states and the
federal government. And the agreement goes something like
that states lead on public, but the federal government
provides technical ex pertise, intellectual resources, financial
resources, because states just can't do all that stuff by
themselves. And what we've had is really a silencing of the
CDC in a way that has left the States alone. And what we've
also had is a federal government on testing that has basically
said to states you're on you r own good luck. Don't call us w e
won't call you. What that has meant is that states are out
there on their own trying to sort this all out. The challenge of
that is not the states can't do it, some s tates can. But the
supply chains for tests are national and international supply
chains. And so there is a reason we have a federal government
and it's not that the federal government should do everything
and they should run all the national testing progra ms . I prefer
state s doing a lot of this, but with support, help aid and
coordination of the federal government, and that's what's
been really lacking.
Margaret Flinter: Well Dr. J ha , you will be teaching this pandemic for years to
come in your school of p ublic health schools of public health
around the country and everybody who comes of age in this
period will have learned what it means to live through COVID. I
think for your average person in the street, one of the kind of
bel aying things that made no sen se to them was we were
sending our healthcare workers into the fire without enough
PPE and the stories you would read having to reuse and wash
your mask and keep working for eight hours straight because
you don't want to use up a set of the PPE , that caugh t the
Dr. Ashish Jha
public's attention in a way that not a lot of things do about in
America. How can this be true that we have such a problem of
getting the right resources to the right people at the right
time, and you've long advocated for a more cogent and
efficient system of allocating resources across this ecosystem?
healthcare? What do you see going forward? It seems like
beyond the state or the federal government, there's just got to
be a whole different way within areas within the country to
get what's needed to the people who need it.
Dr. Ashish Jha: Yeah, so there's a couple of things. One is we have been
thinking a lot about efficiency in healthcare over the last
decade, and that has meant that we have reduced the sort of
extra capacity and surpluses that we'v e had, and this
pandemic is making us pay a price for that.
Margaret Flinter: Yeah.
Dr. Ashish Jha: And then the second is that we assumed again, that while
hospitals and states we're going to be very, very important
that under and a national crisis and re ally a global crisis. The
federal government was going to come to the aid of states and
hospitals. And I think no moment better captured the
absurdity of where we were than when the president's son - in -
law stood up and said, these are not state stockpiles , t his is a
federal stockpile. And I thought, oh, what does that mean?
Because the federal government is supposed to help all of us.
It's not that the federal government's only supposed to help
people who don't live in states. That doesn't make any sense.
Bu t it was a moment, whatever he meant by it, it perfectly
captured for I think, for state leaders , for hospital leaders, a
sense that the idea that we could rely on our federal
government to help us out in a moment of national crisis was
probably not a wise one. And so I think what we're going to
see for the fall, so we're essentially recreating the union in
different ways. So we're going to have a conglom eration of
northeastern states.
Margaret Flinter: Right .
Dr. Ashish Jha: A conglomeration of Midwestern states, one of western
states, and they're all going to go out and create their own
reserves. And so you'll see reserves of PPEs in the
northeastern states and they'll share, you'll see something
similar for the Midwest and maybe the south, and this was th e
job of the federal government. We don't we shouldn't have to
create super state structures of 10 states working together,
how about 50 states working together? But I think in the
future after this pandemic is over , my sense is that states and
Dr. Ashish Jha
hospitals a re going to build their own reserves, because
they're going to work with the assumption that they can't rely
on our federal government to help at a time of crisis, and
that's both inefficient. It's costly.
Margaret Flinter: Yeah.
Dr. Ashish Jha: It's unfor tunate, but I think that will be the one of the major
results, a re examination of why we have a federal
government and whether we can expect that under crisis
situations the federal government is going to be a helpful
player or not.
Mark Masselli: We're s peaking today with Dr. Ashish J ha , Director of the
Harvard Glo bal Health Institute. He's the K.T. Li Professor of
Global Health at Harvard's TH Chan School of Public Health
and he begins work as the Dean of Brown University of public
health in the fall. No w I want to pull the thread on this
conversation which is having with Margaret on the role of the
federal government and early on in the crisis, you wrote that
you thought the US response to the pandemic would be fine,
largely because of the sound infrastr ucture at the Centers for
Disease Control and Prevention. And you mentioned obviously
the snafu around the getting the testing. Right. And you now
say that you were really wrong to make that assumption, as
many experts have been muzzled recently ousted
epi demiologist, Dr. Bright testified before Congress, with the
stark warning that if we don't correct our public health
response, soon, we face the darkest winters ahead. I'm just
wondering, how does the CDC get back to the role that we've
all looked to it to play o r is this a n unraveling of an institution
that valued in our society and plays such an important role.
What's your thinking now? Of how do they regain some trust?
I think it's so important because this isn't the only event that
we're going to face.
Dr. Ashish Jha: Yeah. So I think there are two things. I mean, the good news is
that the CDC continues to have all of its great scientists, they
have not left in l arge numbers. So the CDC is kind of
intellectual horsepower is still there. That is the good news.
And the bad news is obviously they need to be liberated. They
need to be. We need to let them speak. We need to let them
act. The American people have paid for the CDC and the
American people deserve to benefit from the CDC. And the
administration ha s clearly I mean, it's very clear talking to folks
at t he CDC that the administration ha s clearly muzzled the CDC
has said they can't speak up or do things for states that are not
cleared by the White House. And we've just never seen a
Dr. Ashish Jha
situation in the pas t, where a state CDC, a person, a CDC,
expert sitting at a State Department of Health isn't allowed to
really help that State Department of Health without getting
clearance from the White House. But that's essentially where
we are. So first and foremost, t hat needs to stop , that kind of
muzzling . Second, is I do think the CDC has taken a credibility
hit and really in many ways through no fault of their own. I
mean, they've done some things that are really unfortunate
some of their recommendations, some , but they really need so
they do need to kind of regain that trust. But I think that I
don't think that's a hard road fo r them. I don't think it was
going to be very difficult. I think people still respect the CDC.
And I think the CDC was allowed to do its job . They could
quickly regain that trust. That may has been lost a little bit
among the American people, American people I think are very
forgiving of the CDC. If the CDC laws is a lot to get back to it, if
we have an entire year if an entire next year, is t he CDC being
as ineffective and muzzled in the way that it is now, then we
may be a long road to recovery before the CDC gets its trust
back. And the trust is, as we all know, built over the years and
lost within seconds and days. And certainly over a year in a
pandemic, it can be lost very, very effectively.
Margaret Flinter: Well Dr. Jha , I know we share a passion for training the next
generation , and the education of the next generation of
physicians has been very much a part of your work and will
contin ue to be. But when you contemplate all of these
students and their future, I think about former US Surgeon
General , Dr. Vivek Murthy joined us saying they hope that
public health would become much more integral to the
training of ou r frontline medical pati ents pr ofessionals. And I
think that was kind of lost somewhat from the curriculum over
the years in all the health professions, not just in medicine,
and I think everyone's kind of gotten a good realization that
you can't really separate them. How do you see the pandemic,
really factoring into how we train the health professionals of
the future? And will the walls and the lines between public
health and primary care and tertiary care maybe really shift
because of this, at least at the training level?
Dr. A shish Jha: Yeah. So to answer a slightly different question. I actually think
public health will become much more integral to training
people all over the , in all sorts of different fields. It's going to
be hard for people to study economics without unders tanding
some b asic.
Margaret Flinter: Yeah, absolutely.
Dr. Ashish Jha
Dr. Ashish Jha: Right, because one of the things that we have learned is you
can cause massive economic devastation through a public
health crisis that no economic model helps you out of and
helps you understand. So I think that Public Health Education
will become a more important part of all education for some
period of time, but to get to your question more directly,
there's no doubt in my mind that it's that the importance of
public health has reall y been made playing, I think, in the
middle of this pandemic. And it's unfortunate that in some
ways, it took a pandemic. But I , so what that means to me is
physicians, nurses, I think, who have been at the frontlines not
just in taking care of patients, b ut advocating for policy, being
a voice for public health, and will want and need training in
those issues. So they can be more effective advocates for
public health. Because when we fail on public health, it is
doctors and nurses who then have to clean up the mess and
have to deal with the consequences. They clean up the mess
we really have to deal with the consequences of that. So all of
that in my mind is really setting up a rich environment for that
cross - sectoral or cross - disciplinary training, and the question
will be , a re we going to u se that fertile ground to make sure
that that kind of training is happening , that medical students
are learning the basics of public health. And public health
students are learning more about the clinical aspects of the
aspects of clinical medicine that are go ing to be necessary to
manage this. I hope that that is what comes out of it. And that
is definitely part of my agenda at Brown, will be to make sure
that the basics of public health are being taught all across
Unive rsity.
Mark Masselli: We asked you to pull the thread on that and sort of a crystal
ball about the health system itself. What are we learning we,
we realized that we were ill equipped to add ress this? The old
model, a fee - for - service left people scrambling for resources
and couldn't provide it? We found that the inability to make
an impact on chronic diseases left so many people exposed.
We also saw the lack of spending that we make on special
populations impacti ng on us. How do you hope that w hen we
sort o f recast what we have to do, what it might look like, in
the context of so many things that we've lost, where we
probably took our eye off of the end results that we needed to
have.
Dr. Ashish Jha: Yeah. So let me answer that question in two ways. I mean, one
is a very short term answer to just how do we get through the
rest of this pandemic? And how do we rethink our health
system? Part of what happened in March, April and May is we
essentially shut down large chunks of our health system to try
Dr. Ashish Jha
to prepare for the influx of patients with COVID. I n many
places that influx happened in some places that didn't, but
there was an enormous cost to everybody else, including an
enormous cost to the financial viability of the healt h system.
So I think on a short - term basis as we think about the fall,
we're go ing to have to do a lot better preparation for making
sure that doesn't happen. That “ elective surgeries ” can
continue t hat we are able to continue take care of heart attack
and stroke and kidney failure patients. And we don't have the
same, I think really negative effects on all the rest of the
health system. So we have to develop a strategy around that
but that's not really getting a t your question. Your question a s
I heard it was, okay s o let's say we're through this, what is the
new world of healthcare look like?
Margaret Flinter: Right.
Dr. Ashish Jha: And I would say a few things. So first of all, everybody always
used to talk about disruption or disrupt healthcare. And you
know, most of that was really very, i t was tweaking around the
edges on a good day. Well, now we have real disruption
around , and this is an opportunity for us to rethink and redo
things. So I think there have been a bunch of temporary
policies that have been put in that I think are going to become
permanent. I think the idea that telemedicine will somehow go
back to the old policies of not paying for telemedicine, that's
absurd, and more virtual medicine, that stuff is going to
be come, I think, much, much more c ommon, because it's not,
it doe sn't always replace a doctor's visit the in person visit, but
a lot of people go ing to say I like it. I like this way of doing
things. And there's a lot we can do that way. And it's got some
efficiency. So I think there are important regulatory and other
t ypes of changes that we've put in temporarily that will
become permanent. I do also think that it is a chance to think
about issues , about we talked about this a little b it around
how much extra slack d o we want in the system for surges and
for unusual thi ngs that we have not prepared for. And then I
think the issues around fi nancial model , payment model , fee -
for - service capitation, all of those transitions we've been
making, I think are go ing to get accelerated. Because if a
disruption means you can't do e lective surgery, and that
means hospitals basically go bankrupt. That's not a very good
model. And so we have to think about financial models for
hospitals and healthcare system that are and we've been
thinking about it for a while. I just think it acceler ates that
journey much more , b ut a lot of it is, there's going to be how
we, I mean, as long as we don't go back to business as usual,
but I don't think we will. I think this is enough of a change. I
Dr. Ashish Jha
think it would be hard to go back to a pre COVID life an d say,
Al l right, that's done. Now let's go back to maximizing billing.
Margaret Flinter: We've been speaking today with Dr. Ashish Jha, the Director of
the Harvard Global Health Institute, who began a new role as
dean of the Brown University School of Pub lic Health in the
fall. You can follow his important work on COVID - 19 and other
global h ealth issues by going to global health.harvard.edu and
follow him on twitter at a shishkjha Dr . Jha , we want to thank
you for dedicating your intellect and your talent to the great
issues impacting global health for advancing th e discipline of
public health a nd joining us today on Conversations on
Healthcare .
Dr. Ashish Jha: Thank you so much for ha ving me on. I really enjoyed it.
Mark Masselli: At Conversations on Healthc are , w e want our audience to be
truly in the know when it comes to the facts about he alth care
reform and policy. Lori Robertson is an award winning
journal ist and managing editor of factcheck.org a nonpartisan,
nonprofit consumer advocate for voters that aim to reduce the
level of deception in US politics. Lori , what have you got for us
this week?
Lori Robertson: The United States has one of the highest rates of COVID - 19
deaths per capita in the world. However, President Donald
Trump made the false claim t hat “ Germany and the United
States are the two best in deaths per 100,000 people. As of
May 11 , t he day Trump made the claim the US had 24.66
deaths per 100,000 people more than two times higher than
Germany, which had 9.24 deaths per 100,000 people. The U S
had the 11th highest rate out of the more than 140 countries.
tracked by Johns Hopkins University, Germany's was the 18th
highest. Neither coun try is anywhere near the ” lowest rung of
that ladder ” , as the President said in a press briefing at the
White H ouse. It's possible Trump meant to refer to a different
statistics on the John Hopkins University website, the observed
case fatality ratio, that's COVID - 19 deat hs divided by
confirmed cases a mong the 10 countries, the University said
have been most affect ed by the global coronavirus outbreak.
By that limited measure , Germany at 4.4% had the lowest case
fatality ratio and the US at 6% has the second lowest among
those 10 countries. But that's not what Trump said. The
President gave the false impression that the US has one of the
lowest per capita death rates of any nation. It doesn't. And
that's my fact check for this week. I'm Lori Robertson
M anaging Editor of factcheck.org.
Margaret Flinter: FactCheck.org is committed to factual accuracy from the
Dr. Ashish Jha
country's major political players and is a project of the
Annenberg Public Policy Center at the University of
Pennsylvania. If you have a fact that you'd like checked, e - mail
us at www.chcradio.com , we'll have FactCheck.org' s Lori
Robertson check it out for you here on Conversations on
Health Care.
[Music]
Margaret Flinter: Each week ’s c onversation highlights a bright idea about how
to make wellness a part of our communities and everyday
lives.
Margaret Flinter: Childhood Obe sity is a national epidemic but in the south is far
more prevalent. In Louisiana for example, over half of the
children are either obese or overweight, with many
experiencing symptoms such as high blood pressure, high
cholesterol, and pre diabetes. Louisia na State University
researcher Dr. Amanda Sta iano has been studying protocols to
tackle childhood obesity , t apping into readily available
resources that make it easier for kids to adopt better exercise
and activity habits. And since video games are ubiquit ous in
children's lives, she thought that would be a great place to
start.
Dr. Amanda Sta iano: I was trying to think of a way to meet children where they are
to leverage their interests so that they can be more physically
active and hopefully lose weight o r attain a healthy weight.
Children now are spending seven to eight hours every day
using screen technology. Video games are still very popular. So
with these new active video games that require physical
activity to play, I thought this might be an innovat ive way to
make physical activity and exercise fun.
Margaret Flinter: Her team at the Pennington Biomedical Research Center at
LSU developed an intervention called game squad, giving
prescriptions for playing movement video games for a full hour
three time s a week.
Dr. Amanda Staiano: In addition to giving the kids these extra game , we gave them
a few others support. We gave them a challenge book , and
t his would help them to gradually increase the intensity of
their physical activity. We gave them a fitness coach that they
would talk to over their video game. This was a remote
support , a nd the coach would check in with the parent child
once a week and basically help hold them accountable. And
we al so gave the kids a step tracker.
Margaret Flinter: And kids w ere encouraged to have other family members join
Dr. Ashish Jha
them in the movement video games, which added yet another
level of engagement like this young 12 year old boy who
enjoyed gaining a competitive edge over his mom, who was
often dancing right alongside him.
K id : I give the credit to my coach, team mot ivates me, my mom
motivates me.
Kid: I have to say like 60% of the time I will be there. I love to do
disco with my mom.
Margaret Flinter: Dr. Staiano says during the six month game squad trial, over
90% of the ki ds who are given video game prescriptions and a
fitness coach intervention stayed active throughout the study.
The gaming group reduce d their BMI by about 3% while the
control g roups saw an increase in theirs and Staiano says the
added bonus was that kids gained confidence and improve self
esteem with their n ewfound activity, game squad an effective
intervention to increase exercise in sedentary and overweight
kids l everaging already existing video games that are designed
to get kids up and moving, improvin g health and fitness for
kids in a fun, engaging and sustainable way. Now that's a
bright idea.
Mark Masselli: You've been listening Conversations on Health Care, I'm Mark
Masselli.
Margaret Flinter: And I'm Margaret Flinter.
Mark Masselli: Peace and Healt h.
Margaret Flinter: Conversations on Health Care is recorded at WESU at
Wesleyan University, streaming live at chcradio.com , iTunes,
or wherever you listen to podcasts. If you have comments,
please e - mail us at [email protected] or find us on Facebook
or Twitter. We love hearing from you. This show is brought to
you by the Community Health Center.
[Music]